HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maher Albitar Selected Research
Maher Albitar Research Topics
Disease
36
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2002
30
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2020 - 01/2002
29
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 02/2002
26
Neoplasms (Cancer)
01/2022 - 01/2002
22
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2016 - 03/2002
22
Leukemia
01/2016 - 03/2002
16
Hematologic Neoplasms (Hematological Malignancy)
01/2016 - 01/2002
12
Lymphoma (Lymphomas)
01/2021 - 02/2002
11
Multiple Myeloma
06/2011 - 03/2003
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019 - 06/2002
9
Primary Myelofibrosis (Myelosclerosis)
01/2017 - 09/2002
7
Myeloproliferative Disorders (Myeloproliferative Disorder)
03/2011 - 09/2002
6
Disease Progression
01/2017 - 12/2003
5
Chromosome Aberrations (Chromosome Abnormalities)
01/2022 - 08/2002
5
Hematologic Diseases (Blood Diseases)
04/2011 - 03/2003
5
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
05/2008 - 02/2002
5
Fatigue
09/2006 - 04/2003
4
Prostatic Neoplasms (Prostate Cancer)
08/2020 - 03/2014
4
Infections
10/2008 - 05/2002
4
Anemia
05/2006 - 03/2002
3
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 01/2021
3
Cytopenia
12/2020 - 05/2006
3
Blast Crisis (Blast Phase)
12/2008 - 05/2002
3
Hodgkin Disease (Hodgkin's Disease)
02/2007 - 03/2004
3
Non-Hodgkin Lymphoma (Lymphosarcoma)
02/2007 - 03/2004
3
Philadelphia Chromosome
06/2006 - 05/2002
3
Pain (Aches)
04/2004 - 04/2003
3
Headache (Headaches)
01/2004 - 04/2003
3
Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
06/2003 - 06/2002
2
Aplastic Anemia (Anemia, Hypoplastic)
12/2020 - 01/2020
2
Thrombocytopenia (Thrombopenia)
12/2020 - 05/2006
2
Lung Neoplasms (Lung Cancer)
03/2018 - 01/2011
2
Breast Neoplasms (Breast Cancer)
07/2011 - 11/2008
2
Anorexia
06/2011 - 09/2006
2
Neutropenia
06/2011 - 05/2006
2
Hepatocellular Carcinoma (Hepatoma)
04/2011 - 04/2011
2
Liver Diseases (Liver Disease)
04/2011 - 04/2011
2
Myeloid Leukemia (Leukemia, Myelocytic)
08/2009 - 04/2004
2
T-Cell Leukemia (Leukemia, T Cell)
05/2008 - 09/2006
2
Diarrhea
09/2006 - 04/2003
Drug/Important Bio-Agent (IBA)
17
Proteins (Proteins, Gene)
FDA Link
04/2011 - 03/2002
13
Imatinib Mesylate (Gleevec)
FDA Link
10/2016 - 05/2002
11
Biomarkers (Surrogate Marker)
IBA
08/2020 - 06/2002
11
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
07/2007 - 03/2002
10
DNA (Deoxyribonucleic Acid)
IBA
03/2022 - 02/2003
9
Cytarabine (Cytosar-U)
FDA Link
Generic
11/2009 - 05/2002
7
Monoclonal Antibodies
IBA
01/2007 - 02/2002
7
Rituximab (Mabthera)
FDA Link
06/2005 - 02/2002
6
Proteasome Endopeptidase Complex (Proteasome)
IBA
12/2013 - 03/2008
6
fludarabine
IBA
06/2005 - 05/2002
5
RNA (Ribonucleic Acid)
IBA
03/2022 - 01/2007
5
Biological Products
IBA
01/2022 - 08/2002
5
Ubiquitin
IBA
12/2013 - 03/2008
5
Cytokines
IBA
05/2009 - 08/2002
5
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2008 - 08/2002
5
Pharmaceutical Preparations
IBA
09/2006 - 02/2002
5
Enzymes
IBA
05/2006 - 01/2002
4
Thrombopoietin Receptors
IBA
12/2020 - 01/2011
4
Phosphotransferases (Kinase)
IBA
10/2016 - 07/2004
4
Indicators and Reagents (Reagents)
IBA
10/2010 - 05/2006
4
laromustine (VNP40101M)
IBA
11/2009 - 11/2005
4
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
07/2007 - 08/2003
4
Alkylating Agents
IBA
01/2007 - 05/2002
4
Alemtuzumab (Campath)
FDA Link
01/2007 - 05/2002
4
Thalidomide (Thalomid)
FDA Link
05/2006 - 03/2003
4
Antigens
IBA
12/2003 - 02/2002
3
Cell-Free Nucleic Acids
IBA
01/2022 - 01/2016
3
Thrombopoietin (c-mpl Ligand)
IBA
12/2020 - 08/2006
3
Messenger RNA (mRNA)
IBA
08/2020 - 02/2007
3
Formaldehyde (Formol)
FDA Link
07/2011 - 11/2008
3
Paraffin
IBA
07/2011 - 11/2008
3
tanespimycin (17AAG)
IBA
06/2011 - 08/2010
3
TOR Serine-Threonine Kinases
IBA
05/2008 - 11/2005
3
Hemoglobins (Hemoglobin)
IBA
05/2006 - 10/2002
3
Cyclophosphamide (Cytoxan)
FDA Link
Generic
06/2005 - 04/2003
3
Gemtuzumab (Mylotarg)
FDA Link
06/2005 - 03/2003
3
Semaxinib (SU5416)
IBA
07/2004 - 08/2003
3
Telomerase (Telomerase Reverse Transcriptase)
IBA
07/2004 - 03/2003
2
ibrutinib
IBA
01/2021 - 01/2017
2
eltrombopag
FDA Link
12/2020 - 01/2020
2
Tyrosine Kinase Inhibitors
IBA
10/2016 - 09/2003
2
Bortezomib (Velcade)
FDA Link
06/2011 - 08/2010
2
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
05/2010 - 03/2002
2
HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
IBA
05/2010 - 02/2009
2
Immunoglobulins (Immunoglobulin)
IBA
12/2009 - 12/2003
2
A-Form DNA (A-DNA)
IBA
08/2009 - 06/2009
2
Decitabine
FDA Link
08/2009 - 04/2006
2
Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)
IBA
06/2009 - 08/2006
2
Caspase 3 (Caspase-3)
IBA
05/2009 - 06/2002
2
ridaforolimus
IBA
05/2008 - 11/2005
2
Surface Antigens (Surface Antigen)
IBA
01/2007 - 01/2007
2
Antibodies
IBA
01/2007 - 09/2004
2
Everolimus
FDA Link
09/2006 - 11/2005
2
Interleukin-6 (Interleukin 6)
IBA
08/2005 - 09/2002
2
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
05/2004 - 07/2002
2
tipifarnib (R115777)
IBA
04/2004 - 03/2003
2
Transferases
IBA
04/2004 - 03/2003
Therapy/Procedure
29
Therapeutics
01/2021 - 03/2002
5
Drug Therapy (Chemotherapy)
07/2009 - 03/2002
2
Drug Tapering
05/2006 - 04/2004